Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Orthofix Medical
OFIX
Orthofix Medical
Pricing Pressures And Tariffs Will Constrain Margins Yet Allow Recovery
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
08 Aug 25
Updated
08 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$17.00
17.1% undervalued
intrinsic discount
08 Aug
US$14.10
Loading
1Y
-9.9%
7D
12.4%
Author's Valuation
US$17.0
17.1% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$17.0
17.1% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-124m
913m
2014
2017
2020
2023
2025
2026
2028
Revenue US$913.2m
Earnings US$114.1m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
4.85%
Medical Equipment revenue growth rate
0.31%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
8.32%
Calculation
US$114.06m
Earnings '28
x
8.16x
PE Ratio '28
=
US$930.67m
Market Cap '28
US$930.67m
Market Cap '28
/
43.73m
No. shares '28
=
US$21.28
Share Price '28
US$21.28
Share Price '28
Discounted to 2025 @ 8.38% p.a.
=
US$16.72
Fair Value '25
